AGA and ASGE have issued updated recommendations for the surveillance and management of dysplasia in patients with IBD. The consensus statement represents an effort to develop unifying consensus recommendations to address two primary issues: 1) how should surveillance to detect dysplasia be performed, and 2) how should dysplasia be managed.
The consensus statement addresses the optimal types of endoscopic procedures and equipment to be used, recommended practices for removal of lesions, or referral for the more invasive surgical procedure, known as colectomy. In particular, the updated recommendations reflect a shift to using chromoendoscopy for patients with IBD during screening and surveillance to better visualize the tissue. Chromoendoscopy involves the use of dye sprayed onto the mucosa during the procedure, and it often is used in conjunction with other advances in endoscopic imaging.
The new recommendations were developed by an international group of experts and stakeholders in IBD surveillance, in accordance with suggested standards from the Institute of Medicine. Existing guidelines on this topic, which have been written by numerous expert groups, were considered, and in some cases, accepted in the new consensus statement.
The consensus statement was published in the March issues of Gastroenterology and GIE: Gastrointestinal Endoscopy.
